Research Analysts Issue Forecasts for Envision Healthcare Co.’s Q1 2018 Earnings (EVHC)

Envision Healthcare Co. (NYSE:EVHC) – Research analysts at Jefferies Group issued their Q1 2018 earnings estimates for shares of Envision Healthcare in a research note issued on Tuesday. Jefferies Group analyst B. Tanquilut forecasts that the company will post earnings per share of $0.47 for the quarter. Jefferies Group has a “Buy” rating and a $41.00 price target on the stock. Jefferies Group also issued estimates for Envision Healthcare’s Q2 2018 earnings at $0.57 EPS, Q3 2018 earnings at $0.66 EPS and Q4 2018 earnings at $0.70 EPS.

EVHC has been the topic of several other research reports. Bank of America lowered their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, October 9th. Citigroup cut shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a research report on Thursday, November 2nd. Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the company a “hold” rating in a research report on Tuesday, October 31st. Cantor Fitzgerald reissued a “hold” rating and set a $30.00 price target on shares of Envision Healthcare in a research report on Tuesday, November 14th. Finally, SunTrust Banks set a $55.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Sunday, October 15th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $43.25.

Envision Healthcare (NYSE EVHC) traded down $0.14 during trading on Thursday, hitting $34.38. 3,228,389 shares of the stock were exchanged, compared to its average volume of 3,267,165. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $73.00. The stock has a market capitalization of $4,173.10, a price-to-earnings ratio of -6.88, a price-to-earnings-growth ratio of 1.16 and a beta of 0.57. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00.

Envision Healthcare (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. During the same period in the previous year, the company earned $1.13 EPS. Envision Healthcare’s quarterly revenue was up 142.0% compared to the same quarter last year.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Envision Healthcare by 1.8% during the second quarter. Vanguard Group Inc. now owns 11,471,402 shares of the company’s stock worth $718,912,000 after purchasing an additional 204,584 shares in the last quarter. BlackRock Inc. lifted its position in shares of Envision Healthcare by 2.1% during the second quarter. BlackRock Inc. now owns 7,345,283 shares of the company’s stock worth $460,330,000 after purchasing an additional 147,652 shares in the last quarter. Maverick Capital Ltd. lifted its position in shares of Envision Healthcare by 66.2% during the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after purchasing an additional 2,028,026 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Envision Healthcare by 0.3% during the third quarter. Janus Henderson Group PLC now owns 3,958,329 shares of the company’s stock worth $177,927,000 after purchasing an additional 13,242 shares in the last quarter. Finally, OZ Management LP acquired a new stake in shares of Envision Healthcare during the third quarter worth about $131,987,000.

Envision Healthcare announced that its Board of Directors has initiated a stock buyback program on Monday, September 18th that allows the company to buyback $250.00 million in outstanding shares. This buyback authorization allows the company to buy up to 4.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Research Analysts Issue Forecasts for Envision Healthcare Co.’s Q1 2018 Earnings (EVHC)” was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/12/23/research-analysts-issue-forecasts-for-envision-healthcare-co-s-q1-2018-earnings-evhc.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Earnings History and Estimates for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit